	Prospectos 1 299 1 9630,	
co 1 299 1 9629,	
20 1 299 1 8694,	
interrumpisrse 1 299 1 6672,	
notificacionies 1 299 1 6609,	
15 1 299 1 6274,	
beige 1 299 1 5974,	
eu/ 1 299 1 5917,	
europa 1 299 1 5916,	
emea 1 299 1 5915,	
//www 1 299 1 5914,	
http 1 299 1 5913,	
Medicamento 1 299 1 5911,	
Europea 1 299 1 5909,	
Agencia 1 299 1 5908,	
web 1 299 1 5905,	
detallada 1 299 1 5896,	
TEXTO 1 299 1 5893,	
2007 1 299 1 5886,	
21 2 299 2 5882,9494,	
autorización 1 299 1 5881,	
AUTORIZACIÓN/RENOVACIÓN 1 299 1 5873,	
PRIMERA 1 299 1 5872,	
FECHA 2 299 2 5869,5888,	
EU/1/07/383/006 1 299 1 5867,	
EU/1/07/383/005 1 299 1 5866,	
EU/1/07/383/004 1 299 1 5865,	
EU/1/07/383/003 1 299 1 5864,	
EU/1/07/383/002 1 299 1 5863,	
NÚMERO(S) 1 299 1 5857,	
Unido 1 299 1 5855,	
Reino 1 299 1 5854,	
9BU 1 299 1 5853,	
Hertfordshire 1 299 1 5851,	
Hertford 1 299 1 5848,	
Ltd 1 299 1 5847,	
Dohme 1 299 1 5846,	
& 1 299 1 5845,	
	Merck 1 299 1 5843,	
COMERCIALIZACIÓN 2 299 2 5842,5861,	
AUTORIZACIÓN 3 299 3 5840,5859,5876,	
LA 4 299 4 5839,5871,5875,5890,	
local 1 299 1 5835,	
acuerdo 1 299 1 5831,	
realizará 1 299 1 5829,	
contacto 1 299 1 5825,	
hayan 1 299 1 5822,	
materiales 1 299 1 5820,	
utilizado 1 299 1 5815,	
tamaños 1 299 1 5801,	
comercializados 1 299 1 5799,	
estén 1 299 1 5798,	
Puede 1 299 1 5795,	
perforados 1 299 1 5794,	
monodosis 1 299 1 5793,	
blísters 1 299 1 5792,	
98 1 299 1 5778,	
ó 1 299 1 5777,	
84 1 299 1 5776,	
56 1 299 1 5775,	
28 1 299 1 5774,	
Envases 1 299 1 5771,	
EN11 1 299 1 5852,	
(PVC/PE/PVDC 1 299 1 5768,	
envase 1 299 1 5765,	
contenido 1 299 1 5763,	
condiciones 1 299 1 5755,	
conservación 2 299 2 5750,5758,	
Precauciones 2 299 2 5747,5806,	
validez 1 299 1 5742,	
procede 1 299 1 5737,	
amarillo 1 299 1 5731,	
rojo 1 299 1 5726,	
hierro 2 299 2 5725,5730,	
óxido 2 299 2 5723,5728,	
(E171) 1 299 1 5722,	
titanio 1 299 1 5721,	
dióxido 1 299 1 5719,	
(E553b) 1 299 1 5718,	
talco 1 299 1 5717,	
3350 1 299 1 5716,	
macrogol 1 299 1 5715,	
polivinílico 1 299 1 5714,	
alcohol 1 299 1 5713,	
Cubierta 1 299 1 5711,	
sodio 1 299 1 5710,	
estearilo 1 299 1 5708,	
(E470b) 1 299 1 5705,	
estearato 1 299 1 5702,	
(E468) 1 299 1 5701,	
sódica 1 299 1 5700,	
croscarmelosa 1 299 1 5699,	
(E341) 1 299 1 5698,	
anhidro 1 299 1 5697,	
calcio 1 299 1 5696,	
hidrogenofosfato 1 299 1 5694,	
microcristalina 1 299 1 5692,	
celulosa 1 299 1 5691,	
Núcleo 1 299 1 5688,	
Lista 1 299 1 5685,	
	6 1 299 1 5683,	
FARMACÉUTICOS 1 299 1 5682,	
leche/plasma 1 299 1 5675,	
(relación 1 299 1 5674,	
cantidades 1 299 1 5672,	
lactantes 1 299 1 5670,	
márgenes 1 299 1 5648,	
Considerando 1 299 1 5645,	
29 2 299 2 5623,5640,	
crías 1 299 1 5612,	
hipoplásicas 1 299 1 5607,	
(costillas 1 299 1 5605,	
fetales 1 299 1 5600,	
costales 1 299 1 5599,	
malformaciones 1 299 1 5598,	
reproducción 2 299 2 5589,5660,	
mostró 1 299 1 5580,	
postnatal 1 299 1 5573,	
pre 1 299 1 5571,	
desarrollo 1 299 1 5570,	
apareamiento 1 299 1 5564,	
recibieron 1 299 1 5558,	
hembra 1 299 1 5556,	
macho 1 299 1 5554,	
consideran 1 299 1 5534,	
neoplásicas 1 299 1 5531,	
alteraciones 1 299 1 5530,	
hallazgo) 1 299 1 5528,	
(19 1 299 1 5519,	
margen 1 299 1 5516,	
alta 1 299 1 5512,	
secundaria 1 299 1 5503,	
rata 2 299 2 5500,5577,	
tumores 1 299 1 5496,	
hepáticas 1 299 1 5486,	
inducción 1 299 1 5483,	
correlaciona 1 299 1 5478,	
Dado 2 299 2 5475,5513,	
hepáticos 2 299 2 5462,5497,	
carcinomas 1 299 1 5461,	
adenomas 1 299 1 5459,	
produjo 1 299 1 5452,	
ratón 1 299 1 5448,	
carcinógena 1 299 1 5445,	
preclínicos 1 299 1 5441,	
genotoxicidad 1 299 1 5437,	
correspondiente 2 299 2 5426,5619,	
dieron 1 299 1 5400,	
esqueléticos 1 299 1 5396,	
músculos 1 299 1 5395,	
degeneración 1 299 1 5389,	
histológicos 1 299 1 5387,	
encorvada 1 299 1 5381,	
postura 1 299 1 5380,	
y/o 1 299 1 5379,	
temblor 1 299 1 5375,	
blancos 1 299 1 5373,	
espumosos 1 299 1 5372,	
vómitos 1 299 1 5371,	
salivación 1 299 1 5370,	
abierta 1 299 1 5369,	
boca 1 299 1 5368,	
respiración 1 299 1 5365,	
sugirieron 1 299 1 5360,	
EU/1/07/383/001 1 299 1 5862,	
pasajeros 1 299 1 5351,	
físicos 1 299 1 5350,	
signos 2 299 2 5349,5386,	
23 2 299 2 5341,5409,	
perro 1 299 1 5334,	
importancia 1 299 1 5324,	
correspondió 1 299 1 5311,	
base 1 299 1 5295,	
67 1 299 1 5289,	
ratas 7 299 7 5282,5303,5450,5489,5553,5614,5669,	
incisivos 1 299 1 5280,	
anomalías 1 299 1 5277,	
19 2 299 2 5270,8157,	
58 3 299 3 5257,5316,5470,	
correspondientes 5 299 5 5255,5287,5406,5468,5636,	
sistémica 3 299 3 5254,5467,5618,	
roedores 1 299 1 5249,	
observado 2 299 2 5243,5348,	
Road 1 299 1 5849,	
preclinicos 1 299 1 5238,	
Datos 1 299 1 5237,	
farmacocinéticos 1 299 1 5217,	
(IMC) 1 299 1 5196,	
masa 1 299 1 5194,	
índice 1 299 1 5192,	
raza 1 299 1 5189,	
sexo 1 299 1 5187,	
características 2 299 2 5172,5198,	
Otras 1 299 1 5171,	
pediátricos 1 299 1 5170,	
Niños 1 299 1 5160,	
jóvenes 1 299 1 5159,	
19% 1 299 1 5153,	
(65 1 299 1 5141,	
II 2 299 2 5135,5234,	
I 3 299 3 5132,5220,5231,	
fase 5 299 5 5131,5134,5219,5230,5233,	
juzgar 2 299 2 5120,5210,	
Ancianos 1 299 1 5092,	
altere 1 299 1 5087,	
dado 1 299 1 5069,	
existe 1 299 1 5053,	
9) 2 299 2 5051,5066,	
Child-Pugh 2 299 2 5050,5064,	
(puntuación 2 299 2 5048,5062,	
(13 1 299 1 4973,	
precisen 1 299 1 4954,	
cuadriplicó 1 299 1 4938,	
duplicó 1 299 1 4934,	
concentración 1 299 1 4905,	
presentaron 2 299 2 4900,5145,	
así 1 299 1 4885,	
(30 1 299 1 4875,	
80 2 299 2 4872,5143,	
según 1 299 1 4862,	
clasificada 1 299 1 4861,	
incluyó 1 299 1 4855,	
grados 1 299 1 4840,	
diversos 1 299 1 4839,	
(50 2 299 2 4834,4869,	
(E460) 1 299 1 5693,	
abierto 1 299 1 4820,	
Características 1 299 1 4790,	
ligero 2 299 2 4784,5592,	
terapéuticamente 1 299 1 4760,	
250 1 299 1 4755,	
(hasta 1 299 1 4754,	
M) 2 299 2 4745,4756,	
(CI50=160 1 299 1 4744,	
inhibió 1 299 1 4742,	
PEPT1/2 1 299 1 4737,	
transportadores 1 299 1 4736,	
considerables 1 299 1 5673,	
OAT1 1 299 1 4732,	
redujo 1 299 1 4719,	
intervenir 1 299 1 4701,	
hOAT-3 1 299 1 4684,	
clínica 4 299 4 4682,5055,5345,5432,	
relevancia 1 299 1 4681,	
participar 1 299 1 4669,	
(hOAT-3) 1 299 1 4666,	
aniones 1 299 1 4662,	
substrato 1 299 1 4658,	
tubular 1 299 1 4653,	
comporta 1 299 1 4651,	
principalmente 2 299 2 4646,5074,	
produce 1 299 1 4645,	
ml/min 1 299 1 4639,	
350 1 299 1 4638,	
mínima 1 299 1 4628,	
acumula 1 299 1 4625,	
12 2 299 2 4619,5679,	
aparente 1 299 1 4606,	
t1/2 1 299 1 4604,	
siguiente 1 299 1 4599,	
(13%) 1 299 1 4590,	
heces 1 299 1 4589,	
100% 1 299 1 4580,	
Eliminación 1 299 1 4564,	
hallazgos 3 299 3 5327,5420,5652,	
CYP1A2 1 299 1 4563,	
inductor 1 299 1 4559,	
2B6 1 299 1 4554,	
2C19 1 299 1 4552,	
1A2 1 299 1 4551,	
2D6 1 299 1 4550,	
2C9 1 299 1 4549,	
2C8 1 299 1 4548,	
CYP 1 299 1 4546,	
muestran 1 299 1 4536,	
participación 1 299 1 4528,	
ejerce 1 299 1 4507,	
plasma 1 299 1 4505,	
inhibitoria 1 299 1 4500,	
contribuyan 1 299 1 4496,	
espera 1 299 1 4494,	
traza 1 299 1 4490,	
seis 1 299 1 4486,	
detectaron 1 299 1 4485,	
metabolitos 2 299 2 4481,4487,	
excretó 1 299 1 4477,	
radiactividad 2 299 2 4475,4583,	
16% 1 299 1 4472,	
Hoddesdon 1 299 1 5850,	
[C14] 2 299 2 4468,4573,	
79% 1 299 1 4453,	
Aproximadamente 1 299 1 4451,	
orina 3 299 3 4444,4462,4594,	
modificar 2 299 2 4441,4459,	
fundamentalmente 1 299 1 4439,	
elimina 2 299 2 4438,5073,	
Metabolismo 1 299 1 4435,	
(38%) 1 299 1 4434,	
reversiblemente 1 299 1 4427,	
unida 1 299 1 4426,	
fracción 1 299 1 4423,	
intravenosa 1 299 1 4408,	
estacionario 1 299 1 4399,	
distribución 1 299 1 4396,	
volumen 1 299 1 4393,	
Distribución 1 299 1 4391,	
dosis) 2 299 2 4390,4992,	
C24h 2 299 2 4362,4380,	
proporcionalidad 3 299 3 4356,4374,4387,	
establecido 2 299 2 4354,4679,	
198 1 299 1 4420,	
proporcional 1 299 1 4347,	
administrase 1 299 1 4334,	
grasa 1 299 1 4325,	
Puesto 1 299 1 4314,	
87% 1 299 1 4313,	
absoluta 1 299 1 4306,	
950 1 299 1 4302,	
M·hr 1 299 1 4297,	
52 1 299 1 4296,	
Tmax) 1 299 1 4278,	
(mediana 1 299 1 4276,	
mediando 1 299 1 4702,	
máximas 1 299 1 4275,	
alcanzándose 1 299 1 4272,	
absorbió 1 299 1 4270,	
Absorción 1 299 1 4254,	
0%) 1 299 1 4249,	
(32 1 299 1 4248,	
menor 3 299 3 4241,4384,4450,	
9%) 1 299 1 4238,	
(4 1 299 1 4237,	
eficiencia 1 299 1 4208,	
marcador 1 299 1 4205,	
kg) 1 299 1 4194,	
significativo 2 299 2 4181,4910,	
(87%) 1 299 1 4595,	
interrumpieron 1 299 1 4140,	
mg/día 1 299 1 4127,	
requirieron 1 299 1 4119,	
40% 1 299 1 4115,	
día; 1 299 1 4112,	
comparador 1 299 1 4106,	
farmacocinéticas 1 299 1 4253,	
usada 1 299 1 4102,	
inadecuado 1 299 1 4077,	
sulfonilurea) 1 299 1 4070,	
(una 1 299 1 4069,	
semana 2 299 2 4042,4598,	
001 1 299 1 4028,	
p<0 1 299 1 4027,	
anterior 1 299 1 4022,	
antihiperglucémico 1 299 1 4021,	
ajustada 1 299 1 4015,	
página 1 299 1 5904,	
cuadrados 1 299 1 4014,	
tratar) 1 299 1 4010,	
intención 1 299 1 4008,	
análisis 4 299 4 4006,5123,5213,5223,	
(un 1 299 1 4005,	
tratada 1 299 1 4004,	
(N=183) 1 299 1 3979,	
500 1 299 1 3977,	
-1 2 299 2 3974,3992,	
(dos 2 299 2 3964,3982,	
(N=115) 1 299 1 3961,	
+ 4 299 4 3959,3971,3989,4034,	
7) 1 299 1 3939,	
(N=163) 1 299 1 3900,	
229) 1 299 1 3848,	
6) 1 299 1 3846,	
(-1 3 299 3 3843,3936,4188,	
193) 1 299 1 3831,	
(N= 2 299 2 3830,3847,	
día§ 1 299 1 3825,	
-0 12 299 12 3820,3828,3837,3845,3859,3868,3882,3891,3906,3915,3929,3938,	
(%) 3 299 3 3809,3954,4039,	
Media 3 299 3 3801,3946,4011,	
Ensayo 2 299 2 3800,3945,	
combinación* 1 299 1 3799,	
Resultados 1 299 1 3784,	
grupos 1 299 1 3779,	
placebo; 1 299 1 3757,	
neoplasias 1 299 1 5485,	
(500 2 299 2 3716,9612,	
factorial 2 299 2 3695,9591,	
modesta 3 299 3 3681,4970,9577,	
ganancia 2 299 2 3680,9576,	
años) 1 299 1 5144,	
obtuvieron 2 299 2 3678,9574,	
siptagliptina 2 299 2 3677,9573,	
día) 6 299 6 3640,3724,3967,3985,9536,9620,	
(100 2 299 2 3635,9531,	
diseñó 2 299 2 3618,9514,	
notificada 2 299 2 3608,9504,	
hubo 3 299 3 3602,3759,9498,	
comparados 2 299 2 3551,9446,	
glucémicos 4 299 4 3550,3672,9445,9568,	
mejorías 4 299 4 3545,3668,9440,9564,	
proporcionó 4 299 4 3544,3667,9439,9563,	
seguro 2 299 2 3529,9424,	
confirmar 2 299 2 3526,9421,	
observadas 2 299 2 3495,9390,	
magnesio 1 299 1 5704,	
proteínas 1 299 1 4430,	
generalmente 2 299 2 3491,9386,	
GPA 2 299 2 3484,9379,	
HbA1C 2 299 2 3481,9376,	
reducidas 2 299 2 3464,9359,	
tolerabilidad 2 299 2 3461,9356,	
investigaron 2 299 2 3456,9351,	
crónica 4 299 4 3448,4844,5508,9343,	
ningún 3 299 3 3421,5110,9316,	
muestras 2 299 2 3389,9284,	
tolerancia 2 299 2 3384,9279,	
proinsulina 3 299 3 3368,4201,9263,	
Assessment-) 2 299 2 3365,9260,	
Model 2 299 2 3364,9259,	
(Homeostasis 2 299 2 3363,9258,	
HOMA- 2 299 2 3362,9257,	
(subrrogados) 2 299 2 3353,9248,	
disponible 1 299 1 5901,	
indirectos 2 299 2 3352,9247,	
marcadores 2 299 2 3351,9246,	
comparada 5 299 5 3329,3732,4029,9224,9628,	
GPP) 2 299 2 3328,9223,	
(2- 2 299 2 3326,9221,	
opacos 1 299 1 5767,	
(GPA) 2 299 2 3316,9211,	
logró 4 299 4 3303,3725,9198,9621,	
valoración 2 299 2 3268,9163,	
criterio 2 299 2 3266,9161,	
basales 2 299 2 3263,9158,	
HbA1c 7 299 7 3259,3309,3786,4038,4096,9154,9204,	
reducciones 4 299 4 3254,3478,9149,9373,	
medido 2 299 2 3252,9147,	
tiazolidindiona 2 299 2 3251,9146,	
adicional) 2 299 2 3236,9131,	
Naturaleza 1 299 1 5761,	
(tratamiento 2 299 2 3233,9128,	
utilizó 2 299 2 3228,9123,	
administró 2 299 2 3223,9118,	
mejoró 3 299 3 3218,4217,9113,	
DPP-9 2 299 2 3209,9104,	
DPP-8 2 299 2 3207,9102,	
estrechamente 2 299 2 3205,9100,	
enzimas 2 299 2 3204,9099,	
selectivo 2 299 2 3195,9090,	
altamente 2 299 2 3194,9089,	
incrementa 2 299 2 3161,9056,	
sulfonilureas 2 299 2 3158,9053,	
mecanismo 4 299 4 3147,3155,9042,9050,	
postprandial 4 299 4 3145,3321,9040,9216,	
ayunas 4 299 4 3143,3315,9038,9210,	
(HbA1c) 2 299 2 3138,9033,	
A1c 2 299 2 3137,9032,	
bajas 2 299 2 3133,9028,	
producen 2 299 2 3132,9027,	
hiperglucemia 2 299 2 3122,9017,	
presentan 2 299 2 3121,9016,	
comportamiento 2 299 2 3111,9006,	
(E172) 2 299 2 5727,5732,	
Al 2 299 2 3089,8984,	
hidrólisis 2 299 2 3066,8961,	
hepatotoxicidad 1 299 1 5480,	
evita 2 299 2 3064,8959,	
inactivos 2 299 2 3061,8956,	
productos 2 299 2 3060,8955,	
diferente 2 299 2 3153,9048,	
rápidamente 3 299 3 3054,4271,8949,	
actividad 4 299 4 3040,4499,5378,8935,	
altera 2 299 2 3030,8925,	
subidas 2 299 2 3018,8913,	
intensifica 2 299 2 3016,8911,	
estimulación 4 299 4 2988,3010,8883,8905,	
observa 2 299 2 2987,8882,	
manera 4 299 4 2978,4346,4969,8873,	
dependientes 2 299 2 2975,8870,	
glucemia 6 299 6 2965,2982,3731,8860,8877,9627,	
lugar 3 299 3 2959,5401,8854,	
dando 2 299 2 2958,8853,	
reducida 3 299 3 2954,4831,8849,	
producción 2 299 2 2953,8848,	
disminuidas 2 299 2 2943,8838,	
Concentraciones 2 299 2 2940,8835,	
secreción 7 299 7 2933,2998,3163,4652,8828,8893,9058,	
reduce 4 299 4 2931,3104,8826,8999,	
tisular 2 299 2 2925,8820,	
captación 2 299 2 2924,8819,	
aumenta 4 299 4 2922,3098,8817,8993,	
elevados 5 299 5 2921,2947,5647,8816,8842,	
Con 2 299 2 2916,8811,	
biosíntesis 2 299 2 2910,8805,	
estimular 4 299 4 2908,3090,8803,8985,	
grado 4 299 4 2898,3374,8793,9269,	
modelos 2 299 2 2888,8783,	
DPP-4 9 299 9 2886,3051,3073,3199,4503,8781,8946,8968,9094,	
cíclico 2 299 2 2876,8771,	
administrada 1 299 1 4584,	
AMP 2 299 2 2875,8770,	
poblacional 2 299 2 5126,5226,	
interviene 2 299 2 2873,8768,	
intracelulares 2 299 2 2869,8764,	
células 10 299 10 2863,2906,2938,3359,3379,8758,8801,8833,9254,9274,	
liberación 11 299 11 2858,2913,2991,3012,3100,4213,8753,8808,8886,8907,8995,	
síntesis 3 299 3 2856,4211,8751,	
GIP 10 299 10 2853,2972,3008,3045,3088,8748,8867,8903,8940,8983,	
GLP-1 18 299 18 2850,2880,2930,2969,3003,3006,3028,3042,3086,8745,8775,8825,8864,8898,8901,8923,8937,8981,	
elevadas 2 299 2 2848,8743,	
normales 7 299 7 2846,3187,4850,4917,4962,8741,9082,	
homeostasis 2 299 2 2836,8731,	
fisiológica 2 299 2 2833,8728,	
5) 2 299 2 3869,3892,	
regulación 2 299 2 2832,8727,	
participa 2 299 2 2829,8724,	
endógeno 2 299 2 2827,8722,	
forman 2 299 2 2822,8717,	
comida 3 299 3 3387,4322,9282,	
comidas 2 299 2 2819,8714,	
respuesta 8 299 8 2816,2900,3032,3376,8711,8795,8927,9271,	
aumentan 6 299 6 2814,2854,3077,8709,8749,8972,	
intestino 2 299 2 2805,8700,	
liberadas 2 299 2 2802,8697,	
aluminio) 1 299 1 5770,	
(GIP) 2 299 2 2800,8695,	
dependiente 6 299 6 2796,3113,3149,8690,9008,9044,	
insulinotrópico 2 299 2 2795,8689,	
polipéptido 2 299 2 2794,8688,	
(GLP-1) 2 299 2 2791,8685,	
similar 12 299 12 2787,3402,3588,3605,3749,3776,4087,4802,8681,9297,9483,9501,	
péptido 2 299 2 2786,8680,	
incluidos 2 299 2 2784,8678,	
activas 6 299 6 2781,3084,3095,8675,8979,8990,	
incretinas 12 299 12 2780,2783,2821,3057,3070,3094,8674,8677,8716,8952,8965,8989,	
hormonas 6 299 6 2779,3056,3069,8673,8951,8964,	
mediada 2 299 2 2771,8665,	
clínica; 1 299 1 5293,	
podría 3 299 3 2769,4700,8663,	
observada 5 299 5 2765,3395,3752,8659,9290,	
mejoría 8 299 8 2761,3305,3348,3727,8655,9200,9243,9623,	
dipeptidil-peptidasa 2 299 2 2757,8651,	
denominan 2 299 2 2753,8647,	
clase 2 299 2 2747,8641,	
pertenece 2 299 2 2744,8638,	
A10BH01 2 299 2 2741,8636,	
ATC 2 299 2 2740,8635,	
código 2 299 2 2739,8634,	
Grupo 2 299 2 2731,8626,	
farmacodinámicas 2 299 2 2730,8625,	
Propiedades 3 299 3 2729,4252,8624,	
	5 2 299 2 2727,8622,	
ESTE 2 299 2 2725,8620,	
FARMACOLÓGICAS 2 299 2 2723,8618,	
PROPIEDADES 2 299 2 2722,8617,	
diálisis 2 299 2 2719,8614,	
mediante 8 299 8 2718,2865,3253,4016,4971,8613,8760,9148,	
dializable 2 299 2 2717,8612,	
prolongada 2 299 2 2711,8606,	
apropiado 2 299 2 2706,8601,	
reducción 5 299 5 3427,3737,4093,4164,9322,	
hemodiálisis 8 299 8 2697,2710,4892,4955,4972,4979,8592,8605,	
13 2 299 2 2688,8583,	
eliminó 4 299 4 2685,4586,4967,8580,	
dializa 2 299 2 2678,8573,	
instaurar 2 299 2 2671,8566,	
fumarato 1 299 1 5706,	
necesario 2 299 2 2670,8565,	
electrocardiograma) 2 299 2 2666,8561,	
seguimiento 2 299 2 2661,8556,	
realizar 2 299 2 2659,8554,	
digestivo 2 299 2 2658,8553,	
tubo 2 299 2 2657,8552,	
absorbido 2 299 2 2655,8550,	
eliminar 2 299 2 2651,8546,	
habituales 2 299 2 2648,8543,	
soporte 4 299 4 2647,2675,8542,8570,	
medidas 4 299 4 2645,3372,8540,9267,	
razonable 2 299 2 2642,8537,	
sobredosis 2 299 2 2640,8535,	
activa 1 299 1 4654,	
mayores 3 299 3 2629,5154,8524,	
relevantes 6 299 6 2623,3256,4761,5203,8518,9151,	
QTc 2 299 2 2617,8512,	
general 7 299 7 2597,3214,3470,4801,8492,9109,9365,	
800 6 299 6 2592,2608,2631,8487,8503,8526,	
hidroliza 2 299 2 3053,8948,	
únicas 3 299 3 2589,4823,8484,	
sanos 9 299 9 2586,4267,4416,4577,4805,4849,4916,4961,8481,	
sujetos 13 299 13 2585,3186,4266,4415,4576,4804,4848,4915,4960,5137,5157,8480,9081,	
Durante 2 299 2 2579,8474,	
) 2 299 2 2575,8470,	
urticaria 2 299 2 2559,8454,	
cutáneo 2 299 2 2558,8453,	
rash 2 299 2 2557,8452,	
conocida) 2 299 2 2550,8445,	
(frecuencia 2 299 2 2548,8443,	
post-comercialización 4 299 4 2536,2547,8431,8442,	
Experiencia 2 299 2 2535,8430,	
litros 1 299 1 4421,	
QTc) 2 299 2 2529,8424,	
intervalo 2 299 2 2528,8423,	
peptidasa 2 299 2 2737,8632,	
(incluido 2 299 2 2526,8421,	
ECG 2 299 2 2525,8420,	
vitales 2 299 2 2521,8416,	
relevante 4 299 4 2511,5113,5657,8406,	
(N=178) 1 299 1 3997,	
laboratorio 2 299 2 2506,8401,	
parámetros 6 299 6 2504,3549,3671,8399,9444,9567,	
cambio 4 299 4 2501,3578,8396,9473,	
Tratamiento 2 299 2 3962,3980,	
Este 3 299 3 2500,5751,8395,	
mayoría 2 299 2 2492,8387,	
halló 2 299 2 2489,8384,	
observación 2 299 2 2487,8382,	
Esta 2 299 2 2486,8381,	
neutrófilos 2 299 2 2485,8380,	
incremento 4 299 4 2483,4370,4383,8378,	
células/microlitro) 2 299 2 2479,8374,	
medio 8 299 8 2471,3804,3808,3949,3953,4290,4394,8366,	
basal 11 299 11 2470,3414,3586,3764,3802,3947,4026,4173,8365,9309,9481,	
células/microlitro; 2 299 2 2467,8362,	
200 2 299 2 2466,8361,	
(la 3 299 3 2456,4366,8351,	
leucocitos 6 299 6 2455,2459,2473,8350,8354,8368,	
recuento 2 299 2 2453,8348,	
observó 6 299 6 2448,3347,5422,5629,8343,9242,	
primariamente 2 299 2 2436,8331,	
relativas 2 299 2 2432,8327,	
diferencias 2 299 2 2431,8326,	
Fecha 1 299 1 5877,	
corporal 9 299 9 3409,3582,3684,3740,4169,5195,9304,9477,9580,	
7%) 2 299 2 2428,8323,	
(6 2 299 2 2427,8322,	
una) 2 299 2 2421,8316,	
(14 2 299 2 2418,8313,	
comparable 2 299 2 2412,8307,	
exposición 18 299 18 5253,5260,5273,5286,5292,5314,5319,5338,5344,5405,5412,5425,5431,5466,5473,5617,5626,5643,	
global 4 299 4 2351,2390,8246,8285,	
mg) 3 299 3 2348,4835,8243,	
mg/1000 2 299 2 2347,8242,	
ausentes 1 299 1 5606,	
dipeptidil 2 299 2 2736,8631,	
mg/500 2 299 2 2343,8238,	
(sitagliptina/metformina 2 299 2 2341,8236,	
inicial 8 299 8 2332,3234,3704,3963,3981,8227,9129,9600,	
extremidades 2 299 2 2321,8216,	
artrosis 2 299 2 2316,8211,	
control) 2 299 2 2314,8209,	
respecto 4 299 4 2311,3412,8206,9307,	
>0 2 299 2 2309,8204,	
nivel 5 299 5 2295,5265,5415,5523,8190,	
(sin 2 299 2 2292,8187,	
conducen 2 299 2 2950,8845,	
ocurrieron 2 299 2 2282,8177,	
Acontecimientos 2 299 2 2268,8163,	
niveles 21 299 21 2777,2813,2918,2946,3092,3106,3127,3169,4489,5336,5403,5464,5635,8671,8708,8813,8841,8987,9001,9022,9064,	
nasofaringitis 2 299 2 2267,8162,	
resfriado 2 299 2 2265,8160,	
incluyeron 4 299 4 2264,2315,8159,8210,	
produjeron 4 299 4 2250,2301,8144,8196,	
medicación 4 299 4 2246,2279,8140,8174,	
causal 4 299 4 2243,2276,8137,8171,	
§ 1 299 1 4044,	
independientemente 4 299 4 2239,2272,8133,8167,	
adicionales 4 299 4 2237,2270,8131,8165,	
acontecimientos 2 299 2 2235,8129,	
anteriormente 2 299 2 2233,8127,	
envases 1 299 1 5803,	
relacionados 3 299 3 2228,5352,8122,	
media 2 299 2 4099,4165,	
prueba 2 299 2 3382,9277,	
adversos 8 299 8 2227,2236,2269,5548,5582,8121,8130,8164,	
mareo 2 299 2 2222,8116,	
cefalea 2 299 2 2218,8112,	
pancreáticas 4 299 4 2864,2939,8759,8834,	
comparado 6 299 6 2176,3423,3685,8070,9318,9581,	
Además 11 299 11 2154,2223,2928,3026,3476,5382,8048,8117,8823,8921,9371,	
0% 6 299 6 2152,2383,2419,8046,8278,8314,	
placebo/pioglitazona 2 299 2 2144,8038,	
sitagliptina/pioglitazona 2 299 2 2136,8030,	
glimepirida/metformina 4 299 4 2078,2089,7972,7983,	
Sobredosis 2 299 2 2578,8473,	
6% 2 299 2 2033,7927,	
marzo 1 299 1 5884,	
11 3 299 3 2028,5075,7922,	
pequeña 2 299 2 3426,9321,	
placebo/glimepirida 2 299 2 2025,7919,	
sitagliptina/glimepirida 2 299 2 2018,7912,	
TITULAR 1 299 1 5837,	
glimepirida 14 299 14 2000,2054,3643,3647,3661,3664,3922,3958,7894,7948,9539,9543,9557,9560,	
complementarias; 2 299 2 1978,7872,	
(Exploraciones 2 299 2 1977,7871,	
peso 13 299 13 1976,3408,3429,3581,3683,3739,4168,4180,7870,9303,9324,9476,9579,	
disminución 5 299 5 1974,2962,5376,7868,8857,	
+1 1 299 1 4192,	
frecuente) 4 299 4 1972,1980,7866,7874,	
nutrición; 2 299 2 1970,7864,	
(Trastornos 2 299 2 1964,7858,	
anorexia 2 299 2 1963,7857,	
siguientes 4 299 4 1962,2541,7856,8436,	
frente 9 299 9 1916,2460,3487,3761,4170,4190,7810,8355,9382,	
combinados 2 299 2 1906,7800,	
30 3 299 3 1901,4883,7795,	
Periodo 1 299 1 5740,	
14 6 299 6 1897,2382,5300,5773,7791,8277,	
sulfonilurea/metformina 4 299 4 1894,1919,7788,7813,	
Blísters 1 299 1 5766,	
año 4 299 4 1856,1910,7750,7804,	
(DPP-4) 4 299 4 2738,2759,8633,8653,	
adicional 4 299 4 1853,3564,7747,9459,	
1% 8 299 8 1848,2093,2097,2148,7742,7987,7991,8042,	
situación 1 299 1 5539,	
3% 6 299 6 1844,1902,2029,7738,7796,7923,	
placebo/metformina 2 299 2 1840,7734,	
ejercieron 1 299 1 5200,	
comparación 16 299 16 1835,1889,2020,2080,2138,2373,4175,4846,4912,4957,7729,7783,7914,7974,8032,8268,	
sitagliptina/metformina 6 299 6 1833,1887,1915,7727,7781,7809,	
semanas 23 299 23 1802,1987,2041,2105,2163,2327,3338,3345,3559,3623,3698,5301,7696,7881,7935,7999,8057,8222,9233,9240,9454,9519,9594,	
24 20 299 20 1801,1986,2040,2104,2162,2326,3344,3558,3622,3697,7695,7880,7934,7998,8056,8221,9239,9453,9518,9593,	
controlado 6 299 6 1797,3624,3699,7691,9520,9595,	
tomaban 2 299 2 1791,7685,	
comunicados 2 299 2 1779,7673,	
pioglitazona 7 299 7 1774,2119,3576,3899,7668,8013,9471,	
parte 4 299 4 1766,2823,7660,8718,	
sangre 2 299 2 1753,7647,	
glucosa 30 299 30 1751,2799,2839,2844,2903,2927,2956,2974,3020,3112,3141,3148,3171,3312,3320,7645,8693,8734,8739,8798,8822,8851,8869,8915,9007,9036,9043,9066,9207,9215,	
descenso 2 299 2 1746,7640,	
REVISIÓN 1 299 1 5891,	
complementarias 2 299 2 1745,7639,	
Exploraciones 2 299 2 1744,7638,	
periférico 2 299 2 1742,7625,	
edema 2 299 2 1741,7624,	
generales 2 299 2 1740,7623,	
abdominal 2 299 2 1725,7618,	
dolor 4 299 4 1724,2318,7617,8213,	
flatulencia 2 299 2 1720,7613,	
diarrea 2 299 2 1715,7608,	
gastrointestinales 4 299 4 1714,2442,7607,8337,	
nervioso 2 299 2 1709,7602,	
sistema 4 299 4 1708,2826,7601,8721,	
Frecuente 10 299 10 1705,1719,1721,1723,1743,7598,7612,7614,7616,7626,	
frecuente 12 299 12 1702,1704,1712,1717,1727,1750,7595,7597,7605,7610,7620,7644,	
Muy 4 299 4 1701,1703,7594,7596,	
hipoglucemia* 2 299 2 1700,7593,	
relación 9 299 9 2242,2275,3366,3596,4199,8136,8170,9261,9491,	
nutrición 2 299 2 1699,7592,	
Trastornos 8 299 8 1693,1706,1713,1739,7586,7599,7606,7622,	
adversa 4 299 4 1684,1730,7577,7629,	
Cambio 4 299 4 3803,3807,3948,3952,	
controlados 7 299 7 1680,1758,2583,3791,7573,7652,8478,	
identificadas 2 299 2 1676,7569,	
Frecuencia 6 299 6 1672,1685,1731,7565,7578,7630,	
Tabla 5 299 5 1670,3272,3782,7563,9167,	
estreñimiento 4 299 4 1722,2220,7615,8114,	
000) 2 299 2 1669,7562,	
(< 3 299 3 1667,4882,7560,	
comenzó 1 299 1 4986,	
000); 2 299 2 1663,7556,	
1/10 4 299 4 1659,1668,7552,7561,	
raras 4 299 4 1657,1666,7550,7559,	
1/100); 2 299 2 1656,7549,	
000 4 299 4 1654,1660,7547,7553,	
< 11 299 11 1648,1655,1661,3452,4125,4871,4877,7541,7548,7554,9347,	
1/100 2 299 2 1647,7540,	
1/10); 4 299 4 1644,1649,7537,7542,	
( 8 299 8 1643,1646,1652,1658,7536,7539,7545,7551,	
rica 1 299 1 4323,	
frecuentes 8 299 8 1642,1645,1651,3390,7535,7538,7544,9285,	
1/1 4 299 4 1653,1662,7546,7555,	
definen 2 299 2 1639,7532,	
aumento 9 299 9 2451,2774,4178,4902,5454,5491,5593,8346,8668,	
frecuencias 2 299 2 1637,7530,	
sistemas 2 299 2 1633,7526,	
normativa 1 299 1 5834,	
clasificados 2 299 2 1631,7524,	
1) 3 299 3 1630,5678,7523,	
Reacción 4 299 4 1683,1729,7576,7628,	
notificadas 6 299 6 1598,1930,2189,7491,7824,8083,	
consideradas 2 299 2 1592,7485,	
Las 8 299 8 1589,1636,2782,2820,7482,7529,8676,8715,	
paciente) 8 299 8 1580,1616,1951,2208,7473,7509,7845,8102,	
Incompatibilidades 1 299 1 5735,	
2% 8 299 8 1574,1610,1945,2202,7467,7503,7839,8096,	
(> 8 299 8 1572,1608,1943,2200,7465,7501,7837,8094,	
mayor 8 299 8 1571,1607,1942,2199,7464,7500,7836,8093,	
frecuencia 12 299 12 1570,1606,1635,1941,2198,2285,7463,7499,7528,7835,8092,8180,	
notificaron 2 299 2 1567,7460,	
tratamientos 2 299 2 1548,7441,	
5% 13 299 13 1544,1898,2255,2297,2310,2689,4974,7437,7792,8149,8192,8205,8584,	
8% 2 299 2 1535,7428,	
fármaco 28 299 28 1531,1564,1597,1827,1881,1929,2012,2068,2131,2188,2231,2361,2400,2768,7424,7457,7490,7721,7775,7823,7906,7962,8025,8082,8125,8256,8295,8662,	
relacionadas 27 299 27 1528,1561,1594,1824,1878,1926,2009,2065,2128,2185,2358,2397,3206,5601,7421,7454,7487,7718,7772,7820,7903,7959,8022,8079,8253,8292,9101,	
abandonos 2 299 2 1521,7414,	
tasa 2 299 2 1519,7412,	
metformina) 4 299 4 1510,3245,7403,9140,	
(con 4 299 4 1507,3242,7400,9137,	
recibido 2 299 2 1490,7383,	
700 2 299 2 1487,7380,	
duración 8 299 8 1483,1912,2165,3340,7376,7806,8059,9235,	
grande 2 299 2 1475,7368,	
(N=453) 1 299 1 3876,	
número 4 299 4 1474,3512,7367,9407,	
9 17 299 17 1469,1843,2147,2151,2385,2577,3883,3890,3944,3993,5868,7362,7737,8041,8045,8280,8472,	
adversas 36 299 36 1467,1524,1557,1591,1675,1688,1734,1820,1874,1922,2005,2061,2124,2181,2354,2393,2441,2543,7360,7417,7450,7484,7568,7581,7633,7714,7768,7816,7899,7955,8018,8075,8249,8288,8336,8438,	
8 17 299 17 1465,3818,3827,3835,3857,3867,3880,3904,3914,3927,3972,3973,3990,3991,4295,5856,7358,	
somnolencia 4 299 4 1463,1710,7356,7603,	
mareos 2 299 2 1461,7354,	
notificado 4 299 4 1458,2539,7351,8434,	
cuenta 2 299 2 1454,7347,	
realizado 7 299 7 1431,3276,4817,5164,5574,7324,9171,	
máquinas 6 299 6 1427,1443,1450,7320,7336,7343,	
capacidad 4 299 4 1422,1438,7315,7331,	
7 7 299 7 1418,2096,2742,3860,5836,7311,7990,	
excreción 3 299 3 1403,4648,7296,	
humana 10 299 10 1395,5261,5274,5320,5413,5474,5627,5644,5661,7288,	
materna 5 299 5 1394,1409,5631,7287,7302,	
leche 5 299 5 1393,1408,5667,7286,7301,	
excreta 3 299 3 1390,4457,7283,	
Lactancia 2 299 2 1384,7277,	
embarazo 2 299 2 1383,7276,	
humanos 2 299 2 1376,7269,	
hallazgo 1 299 1 5310,	
régimen 4 299 4 1690,1736,7583,7635,	
Ante 2 299 2 1370,7263,	
humano 7 299 7 1369,2636,4665,5331,5543,7262,8531,	
potencial 2 299 2 1365,7258,	
In 1 299 1 4738,	
desconoce 7 299 7 1362,1386,2713,5322,7255,7279,8608,	
altas 2 299 2 1356,7249,	
reproductiva 2 299 2 1353,7246,	
demostrado 7 299 7 1351,1401,2895,5436,7244,7294,8790,	
animales 6 299 6 1349,1399,2889,7242,7292,8784,	
embarazadas 2 299 2 1345,7238,	
mujeres 2 299 2 1344,7237,	
conejos 1 299 1 5633,	
adecuados 2 299 2 1337,7230,	
lactancia 4 299 4 1332,1416,7225,7309,	
Embarazo 4 299 4 1330,1333,7223,7226,	
concomitantemente 2 299 2 1327,7220,	
administren 2 299 2 1326,7219,	
vigilarse 2 299 2 1320,7213,	
mínimos 3 299 3 2615,4013,8510,	
deberán 2 299 2 1319,7212,	
toxicidad 9 299 9 1316,1352,5244,5361,5506,5586,5630,7209,7245,	
(Tabla 2 299 2 1629,7522,	
presenten 2 299 2 1313,7206,	
embargo 7 299 7 1309,1445,4134,4709,5068,7202,7338,	
Sin 7 299 7 1308,1444,4133,4708,5067,7201,7337,	
18% 2 299 2 1299,7192,	
modestamente 2 299 2 2679,8574,	
plasmática 5 299 5 1295,3313,4906,7188,9208,	
11% 2 299 2 1291,7184,	
farmacoterapéutico 2 299 2 2732,8627,	
promedio 4 299 4 1289,1297,7182,7190,	
plasmático 5 299 5 1282,4289,4341,4929,7175,	
aumentos 2 299 2 2614,8509,	
días 2 299 2 1279,7172,	
10 6 299 6 1278,1847,4109,5887,7171,7741,	
durante 13 299 13 1277,1381,1414,2544,2693,4596,4975,5562,7170,7274,7307,8439,8588,	
diariamente 2 299 2 1276,7169,	
0 16 299 16 1265,1534,1573,1609,1944,2201,3819,3836,3844,3858,7158,7427,7466,7502,7838,8095,	
Tras 5 299 5 1260,4255,4463,4565,7153,	
Digoxina 2 299 2 1248,7141,	
moderado 2 299 2 1243,7136,	
e 7 299 7 1236,3369,3445,4202,7129,9264,9340,	
digoxina 15 299 15 1235,1259,1269,1286,1307,1318,1324,4775,7128,7152,7162,7179,7200,7211,7217,	
plasmáticas 11 299 11 1233,1257,3080,4274,4431,4759,4773,5148,7126,7150,8975,	
concentraciones 16 299 16 1232,1256,2842,3079,3134,3211,4273,4758,4772,5147,7125,7149,8737,8974,9029,9106,	
Sitagliptina 27 299 27 1225,1249,2676,3188,3537,3815,3832,3854,3877,3901,3924,3968,3986,4436,4622,4655,4690,4725,4965,5433,5442,5662,7118,7142,8571,9083,9432,	
(OCT) 2 299 2 1224,7117,	
orgánicos 3 299 3 1223,4663,7116,	
cationes 2 299 2 1222,7115,	
pelicular 1 299 1 5712,	
transportador 3 299 3 1220,4660,7113,	
CYP2C9 2 299 2 1218,7111,	
OCT2 1 299 1 4731,	
sustratos 2 299 2 1214,7107,	
causar 2 299 2 1209,7102,	
propensión 2 299 2 1207,7100,	
escasa 2 299 2 1206,7099,	
fertilidad 1 299 1 5551,	
evidencia 2 299 2 1203,7096,	
tenerse 2 299 2 1452,7345,	
proporcionando 2 299 2 1202,7095,	
orales 4 299 4 1201,2750,7094,8644,	
anticonceptivos 2 299 2 1200,7093,	
ataxia 1 299 1 5374,	
warfarina 2 299 2 1198,7091,	
> 9 299 9 1578,1614,1949,2206,5065,7471,7507,7843,8100,	
rosiglitazona 2 299 2 1197,7090,	
gliburida 2 299 2 1195,7088,	
CYP450 2 299 2 1182,7075,	
glucagón 14 299 14 2789,2935,2942,3000,3035,3108,3131,8683,8830,8837,8895,8930,9003,9026,	
isoenzimas 3 299 3 1180,4545,7073,	
compararon 2 299 2 1914,7808,	
induce 2 299 2 1178,7071,	
peritoneal 2 299 2 2720,8615,	
inhibe 4 299 4 1176,3202,7069,9097,	
vivo 6 299 6 1154,1212,1238,7047,7105,7131,	
considera 4 299 4 1147,2509,7040,8404,	
significtivas 2 299 2 1145,7038,	
probenecid 2 299 2 1138,7031,	
inhibido 2 299 2 1134,7027,	
mediado 3 299 3 1130,4749,7023,	
OAT3 7 299 7 1125,1132,1161,4743,7018,7025,7054,	
sustrato 4 299 4 1118,4693,4729,7011,	
transporte 6 299 6 1112,1127,4687,4748,7005,7020,	
evaluado 4 299 4 1103,1152,6996,7045,	
efectos 13 299 13 1087,1435,2226,2967,4328,5201,5417,5547,5581,6980,7328,8120,8862,	
alterar 2 299 2 1071,6964,	
puedan 2 299 2 1070,6963,	
claritromicina) 2 299 2 1069,6962,	
ritonavir 2 299 2 1068,6961,	
itraconazol 2 299 2 1067,6960,	
ketoconazol 2 299 2 1066,6959,	
potentes 4 299 4 1060,1091,6953,6984,	
posible 2 299 2 1056,6949,	
razón 2 299 2 1054,6947,	
terminal 8 299 8 1051,1085,4605,4890,4952,5013,6944,6978,	
nefropatía 7 299 7 1050,1084,4889,4951,5012,6943,6977,	
caso 8 299 8 1048,1096,2638,2669,6941,6989,8533,8564,	
curso 6 299 6 1040,3873,3897,3920,3943,6933,	
claro 1 299 1 5975,	
frecuentemente 2 299 2 2258,8152,	
eliminación 7 299 7 1035,4641,4672,4704,5809,5811,6928,	
importante 2 299 2 1032,6925,	
papel 2 299 2 1019,6912,	
""112"" 1 299 1 5977,	
pequeño 8 299 8 1018,1228,1252,2450,6911,7121,7145,8345,	
formar 2 299 2 3059,8954,	
sólo 3 299 3 1015,4623,6908,	
vía 4 299 4 1011,4449,5077,6904,	
normal 8 299 8 1006,3025,3033,3506,6899,8920,8928,9401,	
probablemente 1 299 1 5501,	
CYP2C8 5 299 5 1000,1217,4531,6893,7110,	
contribución 2 299 2 998,6891,	
CYP3A4 13 299 13 996,1014,1063,1094,1216,4526,4547,4561,6889,6907,6956,6987,7109,	
metabolismo 12 299 12 991,1008,1026,1695,1966,4447,4521,6884,6901,6919,7588,7860,	
limitado 3 299 3 990,4520,6883,	
responsable 3 299 3 988,4518,6881,	
enzima 7 299 7 987,3050,3198,4517,6880,8945,9093,	
principal 3 299 3 986,4516,6879,	
horas 10 299 10 2702,3325,3327,4282,4621,4984,4988,8597,9220,9222,	
indicaron 3 299 3 983,4513,6876,	
vitro 11 299 11 982,1110,1136,1171,4512,4535,4739,6875,7003,7029,7064,	
in 16 299 16 981,1109,1135,1153,1170,1211,1237,4511,4534,6874,7002,7028,7046,7063,7104,7130,	
Ensayos 6 299 6 980,1108,3812,3849,6873,7001,	
gluproteína 2 299 2 978,6871,	
inhibidores 12 299 12 975,1059,1090,1159,2754,2883,6868,6952,6983,7052,8648,8778,	
importantes 2 299 2 972,6865,	
produzcan 2 299 2 970,6863,	
esperar 2 299 2 967,6860,	
significativa 7 299 7 961,3306,3728,4166,6854,9201,9624,	
diferencia 10 299 10 1577,1613,1948,2205,2457,7470,7506,7842,8099,8352,	
aclaramiento 7 299 7 952,1022,4633,4721,4864,6845,6915,	
El 23 299 23 951,1025,1126,2877,3146,3290,3407,3511,3577,4339,4392,4632,4853,5414,6844,6918,7019,8772,9041,9185,9302,9406,9472,	
significativos 4 299 4 950,2517,6843,8412,	
deterioró 1 299 1 4222,	
consideraron 26 299 26 948,1527,1560,1823,1877,1925,2008,2064,2127,2184,2357,2396,2621,6841,7420,7453,7717,7771,7819,7902,7958,8021,8078,8252,8291,8516,	
cambios 7 299 7 940,2515,3124,3760,6833,8410,9019,	
Estos 2 299 2 939,6832,	
respectivamente 14 299 14 938,1849,1903,2034,2098,2153,2387,6831,7743,7797,7928,7992,8047,8282,	
sesión 3 299 3 2695,4977,8590,	
29% 2 299 2 934,6827,	
aproximadamente 20 299 20 932,2465,2476,2686,4113,4311,4419,4470,4578,4618,4637,4932,4936,5151,5340,5408,6825,8360,8371,8581,	
Cmax 7 299 7 928,1294,4299,4359,4367,6821,7187,	
AUC 7 299 7 926,1284,4288,4340,4928,6819,7177,	
valores 6 299 6 924,3262,5251,5284,6817,9157,	
aumentó 7 299 7 922,1287,3411,4344,6815,7180,9306,	
600 4 299 4 918,2478,6811,8373,	
única 5 299 5 906,916,4407,6799,6809,	
oral 8 299 8 905,915,4258,4466,4571,4610,6798,6808,	
p 14 299 14 894,979,1122,1247,2649,4697,4717,4753,4789,6787,6872,7015,7140,8544,	
glucoproteína 10 299 10 893,1121,1246,4696,4716,4752,4788,6786,7014,7139,	
inhibidor 9 299 9 890,1242,3191,4542,4713,4785,6783,7135,9086,	
potente 4 299 4 889,3192,6782,9087,	
ciclosporina 5 299 5 887,921,4711,6780,6814,	
(N=102) 1 299 1 3923,	
(-0 4 299 4 3826,3866,3889,3913,	
cabo 2 299 2 878,6771,	
simvastatina 2 299 2 1196,7089,	
llevó 2 299 2 876,6769,	
Ciclosporina 2 299 2 874,6767,	
farmacocinética 18 299 18 865,897,943,1073,1192,4331,4795,4827,5089,5116,5125,5206,5225,6758,6790,6836,6966,7085,	
supresión 2 299 2 2995,8890,	
significativamente 5 299 5 863,1190,4240,6756,7083,	
observaron 7 299 7 2514,2613,5276,5385,5546,8409,8508,	
alteró 6 299 6 862,958,1189,6755,6851,7082,	
veces 21 299 21 853,2338,3709,3722,3965,3983,5258,5271,5290,5317,5342,5410,5429,5471,5520,5624,5641,6746,8233,9605,9618,	
1000 5 299 5 848,3719,3995,6741,9615,	
repetidas 3 299 3 846,4631,6739,	
coadministración 7 299 7 836,843,901,4317,6729,6736,6794,	
significativas 4 299 4 833,3546,6726,9441,	
ligera 2 299 2 5390,5393,	
clínicamente 19 299 19 832,949,1144,2510,2516,2622,2705,3255,4909,5112,5202,6725,6842,7037,8405,8411,8517,8600,9150,	
interacciones 8 299 8 831,971,1143,1210,6724,6864,7036,7103,	
sugieren 5 299 5 826,1172,5654,6719,7065,	
continuación 4 299 4 825,1628,6718,7521,	
comparaba 1 299 1 4049,	
descritos 4 299 4 823,2232,6716,8126,	
fármacos 4 299 4 817,1167,6710,7060,	
Efectos 6 299 6 814,1162,1419,6707,7055,7312,	
interacción 2 299 2 813,6706,	
formas 4 299 4 811,3083,6704,8978,	
Interacción 2 299 2 804,6697,	
alternativo 2 299 2 797,6690,	
establecer 2 299 2 791,6684,	
7% 2 299 2 2386,8281,	
acontecimiento 2 299 2 789,6682,	
potenciales 2 299 2 787,6680,	
causas 2 299 2 786,6679,	
evaluar 9 299 9 784,882,3280,3628,4825,6677,6775,9175,9524,	
reacción 2 299 2 775,6668,	
sospecha 2 299 2 772,6665,	
hay 6 299 6 771,1335,2625,6664,7228,8520,	
después 5 299 5 765,4283,4400,4989,6658,	
sucedieron 2 299 2 764,6657,	
inicio 2 299 2 757,6650,	
meses 2 299 2 754,6647,	
primeros 2 299 2 753,6646,	
tres 2 299 2 752,6645,	
ocurrió 2 299 2 749,6642,	
aparición 2 299 2 745,6638,	
Stevens-Johnson 4 299 4 743,2570,6636,8465,	
síndrome 4 299 4 741,2568,6634,8463,	
incluido 2 299 2 739,6632,	
piel 4 299 4 738,2565,6631,8460,	
exfoliativas 4 299 4 735,2562,6628,8457,	
enfermedades 4 299 4 734,2561,6627,8456,	
angioedema 4 299 4 732,2556,6625,8451,	
conducir 8 299 8 1424,1440,1447,3176,7317,7333,7340,9071,	
anafilaxia 4 299 4 731,2555,6624,8450,	
incluyen 2 299 2 730,6623,	
graves 2 299 2 720,6613,	
postautorización 2 299 2 717,6610,	
toleraron 2 299 2 2599,8494,	
recogido 2 299 2 715,6608,	
interés 1 299 1 5536,	
han 20 299 20 714,1102,1350,1400,1430,1457,1489,2538,3275,5163,5347,6607,6995,7243,7293,7323,7350,7382,8433,9170,	
Se 24 299 24 713,875,1361,1385,2537,2712,3274,3346,3617,4484,4815,5241,5275,5321,5628,6606,6768,7254,7278,8432,8607,9169,9241,9513,	
hipersensibilidad 8 299 8 712,722,777,2553,6605,6615,6670,8448,	
Reacciones 4 299 4 710,1466,6603,7359,	
deben 2 299 2 701,6594,	
Como 2 299 2 687,6580,	
Insuficiencia 4 299 4 685,4813,5028,6578,	
insulina 24 299 24 684,2860,2915,2920,2949,2993,3014,3102,3129,3165,3370,4203,4216,6577,8755,8810,8815,8844,8888,8909,8997,9024,9060,9265,	
adecuadamente 2 299 2 676,6569,	
superior 9 299 9 642,1728,2307,2423,4371,6535,7621,8202,8318,	
Poco 8 299 8 1711,1716,1726,1749,7604,7609,7619,7643,	
incidencia 27 299 27 638,1817,1871,2002,2058,2121,2306,2350,2389,3392,3604,3772,4229,5457,5494,5596,6531,7711,7765,7896,7952,8015,8201,8245,8284,9287,9500,	
combina 2 299 2 633,6526,	
placebo 47 299 47 630,646,1624,1682,1792,1799,2085,2178,2216,2379,2462,3331,3406,3435,3475,3489,3553,3598,3616,3626,3691,3701,3793,4031,4033,6523,6539,7517,7575,7686,7693,7979,8072,8110,8274,8357,9226,9301,9330,9370,9384,9448,9493,9512,9522,9587,9597,	
tratados 62 299 62 628,703,725,1552,1586,1601,1622,1831,1885,1933,1957,2016,2023,2072,2083,2134,2142,2193,2214,2261,2289,2364,2377,2403,3398,3433,3592,3612,3675,3689,4159,4185,6521,6596,6618,7445,7479,7494,7515,7725,7779,7827,7851,7910,7917,7966,7977,8028,8036,8087,8108,8155,8184,8259,8272,8298,9293,9328,9487,9508,9571,9585,	
Estas 3 299 3 728,5197,6621,	
similares 8 299 8 621,1783,3471,3492,6514,7677,9366,9387,	
notificados 6 299 6 617,2238,2271,6510,8132,8166,	
(incluso 2 299 2 2663,8558,	
índices 8 299 8 614,624,1776,1786,6507,6517,7670,7680,	
pioglitazona) 2 299 2 612,6505,	
conocido 2 299 2 607,6500,	
hipoglucemiente 2 299 2 605,6498,	
combinada 2 299 2 599,6492,	
biodisponibilidad 1 299 1 4305,	
terapia 6 299 6 598,2329,3703,6491,8224,9599,	
Metformina 2 299 2 841,6734,	
monoterapia 18 299 18 595,1762,2159,3225,3289,3302,3500,3735,3790,3814,4084,6488,7656,8053,9120,9184,9197,9395,	
clínicos 18 299 18 591,822,1186,1471,1679,1757,2446,2582,2683,6484,6715,7079,7364,7572,7651,8341,8477,8578,	
ensayos 46 299 46 590,1185,1347,1397,1432,1470,1517,1678,1756,1905,2157,2445,2495,2581,2682,3278,3334,3498,3556,3601,3788,3795,4510,5165,5440,5584,6483,7078,7240,7290,7325,7363,7410,7571,7650,7799,8051,8340,8390,8476,8577,9173,9229,9393,9451,9497,	
antihiperglucemiantes 4 299 4 587,2749,6480,8643,	
medicamentos 9 299 9 586,601,808,838,6479,6494,6701,6731,9632,	
Hipoglucemia 2 299 2 577,6470,	
diabética 2 299 2 576,6469,	
cetoacidosis 2 299 2 575,6468,	
3) 3 299 3 1360,3916,7253,	
utilizarse 6 299 6 561,1379,1412,6454,7272,7305,	
Generales 2 299 2 558,6451,	
especiales 5 299 5 555,5748,5756,5807,6448,	
precauciones 2 299 2 554,6447,	
Advertencias 2 299 2 552,6445,	
8) 6 299 6 549,650,801,6442,6543,6694,	
activo 2 299 2 536,6429,	
previsible 1 299 1 5081,	
principio 2 299 2 535,6428,	
68% 2 299 2 937,6830,	
Hipersensibilidad 2 299 2 533,6426,	
material 2 299 2 2653,8548,	
Contraindicaciones 2 299 2 532,6425,	
eficacia 8 299 8 529,3282,3630,4051,4148,6422,9177,9526,	
falta 5 299 5 522,1372,4146,6415,7265,	
18 8 299 8 517,2092,3337,4043,6410,7627,7986,9232,	
secreta 1 299 1 5664,	
indican 2 299 2 1626,7519,	
menores 2 299 2 515,6408,	
niños 2 299 2 514,6407,	
utilizar 8 299 8 511,1426,1442,1449,6404,7319,7335,7342,	
pediátrica 2 299 2 507,6400,	
Población 2 299 2 506,6399,	
precaución 2 299 2 505,6398,	
actuarse 2 299 2 503,6396,	
limitados 2 299 2 500,6393,	
son 10 299 10 499,2801,2845,2973,3172,6392,8696,8740,8868,9067,	
años 7 299 7 498,518,1481,5744,6391,6411,7374,	
75 2 299 2 497,6390,	
bajos 2 299 2 3173,9068,	
disponibles 2 299 2 492,6385,	
seguridad 14 299 14 491,527,3285,3458,3632,4054,5240,5518,5650,6384,6420,9180,9353,9528,	
datos 16 299 16 489,524,821,1169,1336,1374,4533,5129,5216,5228,6382,6417,6714,7062,7229,7267,	
Los 22 299 22 488,820,1086,1168,1346,1396,2966,3673,4157,4509,4532,4893,5136,5583,6381,6713,6979,7061,7239,7289,8861,9569,	
función 12 299 12 484,1004,1030,3356,3504,5102,5185,6377,6897,6923,9251,9399,	
precisa 5 299 5 478,5032,5095,5178,6371,	
avanzada 3 299 3 475,5140,6368,	
edad 9 299 9 474,487,496,5105,5107,5139,6367,6380,6389,	
estudiado 4 299 4 464,675,6357,6568,	
hepática 14 299 14 445,457,470,2957,5029,5044,5060,5085,5247,5507,6338,6350,6363,8852,	
2) 11 299 11 441,671,709,3273,3510,5027,6334,6564,6602,9168,9405,	
5 18 299 18 440,708,803,1359,2721,3509,3821,4126,4189,4250,5235,5760,6333,6601,6696,7252,8616,9404,	
población 3 299 3 435,4001,6328,	
indica 1 299 1 4778,	
recomienda 7 299 7 428,510,1302,4995,6321,6403,7195,	
Por 8 299 8 424,651,962,1052,6317,6544,6855,6945,	
limitada 7 299 7 423,691,3047,5023,6316,6584,8942,	
primera 3 299 3 768,5880,6661,	
grave 17 299 17 421,471,699,1045,1081,3521,4881,4945,5007,5061,5086,6314,6364,6592,6938,6974,9416,	
moderada 12 299 12 419,460,697,3519,4874,4926,5005,5047,6312,6353,6590,9414,	
clínico 7 299 7 411,1107,2662,4765,6304,7000,8557,	
ensayo 38 299 38 410,880,1106,1796,1852,1984,2038,2102,2324,2603,3270,3422,3438,3620,3694,4047,4132,4197,4764,4819,4854,5298,5567,6303,6773,6999,7690,7746,7878,7932,7996,8219,8498,9165,9317,9333,9516,9590,	
experiencia 10 299 10 408,689,2546,2626,5017,5054,6301,6582,8441,8521,	
combinado 1 299 1 5214,	
ajuste 11 299 11 402,450,480,1303,5034,5097,5180,6295,6343,6373,7196,	
requiere 5 299 5 400,448,5754,6293,6341,	
ml/min) 7 299 7 397,3454,4873,4879,4884,6290,9349,	
[CrCl] 2 299 2 395,6288,	
creatinina 5 299 5 394,3451,4866,6287,9346,	
(aclaramiento 4 299 4 392,3449,6285,9344,	
reacciones 42 299 42 719,729,748,1523,1556,1590,1674,1687,1733,1819,1873,1921,2004,2060,2123,2180,2353,2392,2440,2542,2551,6612,6622,6641,7416,7449,7483,7567,7580,7632,7713,7767,7815,7898,7954,8017,8074,8248,8287,8335,8437,8446,	
leve 7 299 7 391,458,4868,4898,5045,6284,6351,	
En 55 299 55 386,588,1001,1183,1468,1515,1549,1755,1794,1850,1904,1982,2036,2100,2322,2443,2601,2637,2680,3114,3213,3436,3599,3692,4045,4195,4762,4920,5332,5449,5565,6279,6481,6894,7076,7361,7408,7442,7649,7688,7744,7798,7876,7930,7994,8217,8338,8496,8532,8575,9009,9108,9331,9495,9588,	
renal 40 299 40 385,390,418,686,696,953,1005,1044,1080,1099,3447,3505,3517,4634,4649,4673,4705,4722,4814,4843,4860,4897,4925,4944,5004,5078,5245,6278,6283,6311,6579,6589,6846,6898,6937,6973,6992,9342,9400,9412,	
insuficiencia 33 299 33 384,389,417,444,456,469,695,1043,1079,1098,3446,3516,4842,4859,4896,4924,4943,5003,5043,5059,5084,6277,6282,6310,6337,6349,6362,6588,6936,6972,6991,9341,9411,	
Pacientes 6 299 6 382,442,472,6275,6335,6365,	
alcanzar 2 299 2 2293,8188,	
alimentos 3 299 3 380,4338,6273,	
acodadas) 1 299 1 5609,	
incluyendo 7 299 7 1009,2554,2566,5008,6902,8449,8461,	
doble 2 299 2 370,6263,	
No 38 299 38 365,446,461,476,508,559,672,1149,1300,1334,1410,1428,2512,2624,4351,4676,4993,5030,5052,5093,5161,5176,5544,5736,6258,6339,6354,6369,6401,6452,6565,7042,7193,7227,7303,7321,8407,8519,	
acuerde 2 299 2 364,6257,	
paciente 2 299 2 362,6255,	
tomarse 6 299 6 358,367,376,6251,6260,6269,	
omite 2 299 2 352,6245,	
Si 8 299 8 350,770,2703,2840,6243,6663,8598,8735,	
4) 3 299 3 349,3829,6242,	
hemoglobina 2 299 2 3136,9031,	
apartado 21 299 21 347,439,544,648,669,707,799,1358,2572,3508,5025,6240,6332,6437,6541,6562,6600,6692,7251,8467,9403,	
(ver 23 299 23 346,438,543,647,668,706,798,1357,2571,3271,3507,5024,6239,6331,6436,6540,6561,6599,6691,7250,8466,9166,9402,	
hipoglucemia 22 299 22 345,616,640,667,1778,2219,3038,3178,3394,3607,3774,4231,6238,6509,6533,6560,7672,8113,8933,9073,9289,9503,	
riesgo 13 299 13 343,665,829,1141,1314,1364,5656,6236,6558,6722,7034,7207,7257,	
reducir 4 299 4 341,663,6234,6556,	
baja 7 299 7 337,659,2984,4433,6230,6552,8879,	
dar 4 299 4 333,655,6226,6548,	
considerarse 6 299 6 332,654,2708,6225,6547,8603,	
Cuando 4 299 4 322,631,6215,6524,	
concomitante 6 299 6 321,1157,1263,6214,7050,7156,	
constantes 2 299 2 2520,8415,	
administrarse 2 299 2 318,6211,	
debe 18 299 18 317,357,366,502,560,778,1378,1411,1451,6210,6250,6259,6395,6453,6671,7271,7304,7344,	
posología 2 299 2 307,6200,	
mantenerse 2 299 2 305,6198,	
Debe 2 299 2 304,6197,	
glipizida 8 299 8 4068,4090,4101,4123,4156,4187,4227,4247,	
día 38 299 38 303,373,855,1498,1540,1811,1865,1996,2050,2117,2174,2340,2810,3300,3543,3711,3842,3864,3887,3911,3934,4066,6196,6266,6748,7391,7433,7705,7759,7890,7944,8011,8068,8235,8705,9195,9438,9607,	
vez 27 299 27 301,1809,1863,1994,2048,2115,2172,3298,3541,3638,3823,3840,3862,3885,3909,3932,4064,6194,7703,7757,7888,7942,8009,8066,9193,9436,9534,	
100 38 299 38 298,908,1272,1493,1537,1804,1858,1935,1989,2043,2110,2167,3293,3538,3816,3833,3855,3878,3902,3925,4059,4263,4410,4612,6191,6801,7165,7386,7430,7698,7752,7829,7883,7937,8004,8061,9188,9433,	
náuseas 2 299 2 1718,7611,	
La 34 299 34 292,407,744,842,900,2388,2760,3039,3062,3391,3652,3736,3771,4097,4228,4304,4422,4603,4640,4794,5106,5810,5894,6185,6300,6637,6735,6793,8283,8654,8934,8957,9286,9548,	
x 1 299 1 5785,	
efecto 13 299 13 604,884,1229,1253,4769,5111,5267,5307,5525,6497,6777,7122,7146,	
administración 10 299 10 291,1156,1262,4257,4403,4567,4602,6184,7049,7155,	
forma 8 299 8 289,320,960,4479,4627,6182,6213,6853,	
Inhibidor 2 299 2 2733,8628,	
Posología 2 299 2 287,6180,	
tiazolidinadiona) 2 299 2 250,6143,	
ej 8 299 8 248,609,1065,2650,6141,6502,6958,8545,	
(p 6 299 6 247,608,1064,6140,6501,6957,	
PPAR 10 299 10 246,259,277,313,1514,6139,6152,6170,6206,7407,	
agonista 10 299 10 245,258,276,312,1513,6138,6151,6169,6205,7406,	
agentes 2 299 2 221,6114,	
dual 2 299 2 218,6111,	
intolerancia 2 299 2 189,6082,	
o 64 299 64 188,310,378,420,459,537,611,698,1046,1082,1199,1448,1500,1508,1511,1773,2345,2522,2847,2881,3208,3235,3243,3615,3645,3663,3718,3756,4032,4067,4336,4553,4591,5006,5046,5190,5391,6081,6203,6271,6313,6352,6430,6504,6591,6939,6975,7092,7341,7393,7401,7404,7667,8240,8417,8742,8776,9103,9130,9138,9511,9541,9559,9614,	
corresponde 1 299 1 5268,	
contraindicaciones 2 299 2 187,6080,	
debido 9 299 9 185,519,2437,2480,4143,6078,6412,8332,8375,	
adecuada 2 299 2 184,6077,	
* 3 299 3 1754,3998,7648,	
sea 4 299 4 183,251,6076,6144,	
tolerada 2 299 2 167,6060,	
máxima 2 299 2 166,6059,	
dosis 59 299 59 165,293,335,354,369,404,452,482,657,769,845,904,914,1305,1355,2588,2606,2628,2692,3463,4098,4121,4261,4286,4350,4365,4377,4406,4465,4570,4609,4630,4822,4830,5037,5100,5183,5398,5511,6058,6186,6228,6247,6262,6297,6345,6375,6550,6662,6738,6797,6807,7198,7248,8483,8501,8523,8587,9358,	
sulfonilurea 20 299 20 150,170,200,330,339,636,661,1506,1959,3241,6043,6063,6093,6223,6232,6529,6554,7399,7853,9136,	
adecuado 10 299 10 139,177,227,252,284,6032,6070,6120,6145,6177,	
vías 2 299 2 2866,8761,	
logren 8 299 8 135,173,223,280,6028,6066,6116,6173,	
sola 16 299 16 133,171,2417,2426,2435,3644,3662,3755,3770,6026,6064,8312,8321,8330,9540,9558,	
tratamiento 52 299 52 130,217,273,572,759,781,793,1491,1692,1738,1768,1838,1892,2532,2673,2878,3291,3417,3563,3781,3797,3851,3871,3895,3918,3941,4020,4035,4080,4142,4225,5355,5604,6023,6110,6166,6465,6652,6674,6686,7384,7585,7637,7662,7732,7786,8427,8568,8773,9186,9312,9458,	
(EMEA) 1 299 1 5912,	
añadida 6 299 6 3641,3865,3893,3912,3935,9537,	
ejercicio 8 299 8 126,161,213,270,6019,6054,6106,6163,	
dieta 8 299 8 123,158,210,267,6016,6051,6103,6160,	
casos 12 299 12 118,153,205,262,763,1459,6011,6046,6098,6155,6656,7352,	
metformina 51 299 51 115,132,181,202,309,610,851,1194,1504,1772,1815,1869,2056,2336,2371,2410,2416,3232,3569,3651,3666,3715,3747,3754,3875,3960,3976,3994,4082,6008,6025,6074,6095,6202,6503,6744,7087,7397,7666,7709,7763,7950,8231,8266,8305,8311,9127,9464,9547,9562,9611,	
combinación 55 299 55 113,147,197,255,327,582,682,1502,1770,1813,1867,1998,2052,2076,2087,2108,2331,2367,2406,3230,3238,3248,3567,3574,3649,3713,3743,3853,4037,6006,6040,6090,6148,6220,6475,6575,7395,7664,7707,7761,7892,7946,7970,7981,8002,8226,8262,8301,9125,9133,9143,9462,9469,9545,9609,	
glucémico 19 299 19 111,138,145,176,195,226,283,2764,3217,4076,6004,6031,6038,6069,6088,6119,6176,8658,9112,	
control 24 299 24 110,137,144,175,194,225,282,1588,2763,3216,4075,4852,4919,4964,6003,6030,6037,6068,6087,6118,6175,7481,8657,9111,	
neural 1 299 1 5362,	
mejorar 8 299 8 108,142,192,2896,6001,6035,6085,8791,	
elevado 1 299 1 5515,	
· 8 299 8 106,140,190,253,5999,6033,6083,6146,	
tipo 19 299 19 104,236,567,872,2892,3118,3183,3443,3534,4811,5997,6129,6460,6765,8787,9013,9078,9338,9429,	
mellitus 4 299 4 103,235,5996,6128,	
diabetes 19 299 19 102,234,566,796,871,2891,3117,3182,3442,4810,5995,6127,6459,6689,6764,8786,9012,9077,9337,	
pacientes 122 299 122 100,232,387,415,437,454,467,494,564,627,693,724,869,1002,1077,1311,1477,1488,1551,1585,1600,1621,1789,1830,1884,1932,1956,2015,2071,2133,2141,2192,2213,2260,2288,2363,2376,2402,3115,3180,3397,3432,3440,3502,3514,3536,3591,3611,3674,3688,3767,4003,4072,4118,4150,4158,4184,4793,4808,4837,4857,4887,4894,4922,4941,4949,5001,5020,5041,5057,5169,5175,5993,6125,6280,6308,6330,6347,6360,6387,6457,6520,6586,6617,6762,6895,6970,7204,7370,7381,7444,7478,7493,7514,7683,7724,7778,7826,7850,7909,7965,8027,8035,8086,8107,8154,8183,8258,8271,8297,9010,9075,9292,9327,9335,9397,9409,9431,9486,9507,9570,9584,	
indicado 4 299 4 98,230,5991,6123,	
está 7 299 7 97,229,3046,5900,5990,6122,8941,	
Januvia 66 299 66 96,228,295,323,356,374,406,413,432,465,512,562,593,705,727,761,783,1275,1342,1380,1413,1496,1760,2263,2291,2303,2534,2743,3287,3400,4062,4319,4332,4999,5039,5167,5989,6121,6188,6216,6249,6267,6299,6306,6325,6358,6405,6455,6486,6598,6620,6654,6676,7168,7235,7273,7306,7389,7654,8158,8186,8198,8429,8637,9182,9295,	
terapéuticas 4 299 4 95,3212,5988,9107,	
Indicaciones 2 299 2 94,5987,	
	4 2 299 2 92,5985,	
CLÍNICOS 2 299 2 91,5984,	
DATOS 3 299 3 90,5681,5983,	
4 53 299 53 89,285,348,530,545,546,548,550,551,649,670,800,802,1328,1417,1464,2099,2573,2574,2576,2701,2758,3905,3975,4281,4620,4983,4987,5026,5677,5746,5982,6178,6241,6423,6438,6439,6441,6443,6444,6542,6563,6693,6695,7221,7310,7357,7993,8468,8469,8471,8596,8652,	
" 2 299 2 88,5981,	
cara 2 299 2 87,5980,	
""221"" 1 299 1 84,	
rosa 1 299 1 82,	
color 2 299 2 81,5973,	
Sharp 1 299 1 5844,	
redondo 2 299 2 79,5971,	
Comprimido 2 299 2 75,5967,	
(comprimido) 2 299 2 74,5966,	
recubierto 4 299 4 71,76,5963,5968,	
	"Comprimido 2 299 2 70,5962,	
FARMACÉUTICA 2 299 2 69,5961,	
FORMA 2 299 2 68,5960,	
3 15 299 15 67,531,2035,2699,3907,3928,4664,4981,5236,5739,5743,5959,6424,7929,8594,	
6 18 299 18 65,1329,2032,2477,3838,3930,5428,5680,5733,5738,5745,5759,5804,5805,5957,7222,7926,8372,	
sección 2 299 2 64,5956,	
mostraron 4 299 4 1113,4162,5590,7006,	
ver 2 299 2 63,5955,	
excipientes 5 299 5 62,542,5687,5954,6435,	
completa 2 299 2 60,5952,	
lista 2 299 2 59,5951,	
consultar 2 299 2 57,5949,	
Para 4 299 4 56,3004,5948,8899,	
equivale 2 299 2 50,5942,	
monohidrato 2 299 2 48,5940,	
sitagliptina 164 299 164 47,55,316,619,634,680,819,860,867,899,911,930,945,955,993,1024,1037,1075,1115,1129,1164,1174,1187,1322,1388,1405,1554,1603,1764,1781,1807,1861,1938,1992,2046,2074,2113,2170,2195,2334,2369,2408,2425,2434,2595,2611,2715,3063,3097,3151,3220,3296,3419,3466,3486,3531,3561,3594,3614,3634,3655,3705,3745,3769,4085,4139,4161,4219,4236,4268,4292,4308,4343,4413,4425,4455,4469,4483,4508,4523,4538,4574,4615,4643,4675,4689,4707,4724,4740,4766,4780,4797,4833,4908,4931,5071,5091,5118,5150,5208,5559,5578,5939,5947,6209,6512,6527,6573,6712,6753,6760,6792,6804,6823,6838,6848,6886,6917,6930,6968,7008,7022,7057,7067,7080,7215,7281,7298,7447,7496,7658,7675,7701,7755,7832,7886,7940,7968,8007,8064,8089,8229,8264,8303,8320,8329,8490,8506,8610,8958,8992,9046,9115,9191,9314,9361,9381,9426,9456,9489,9510,9530,9551,9601,	
fosfato 2 299 2 45,5937,	
contiene 2 299 2 44,5936,	
comprimido 3 299 3 43,5690,5935,	
	Cada 2 299 2 42,5934,	
nM 1 299 1 4303,	
CUANTITATIVA 2 299 2 41,5933,	
Y 2 299 2 40,5932,	
CUALITATIVA 2 299 2 39,5931,	
COMPOSICIÓN 2 299 2 38,5930,	
2 33 299 33 37,105,237,286,381,873,1480,1486,1981,2893,3119,3184,3324,3333,3444,3783,4251,4812,5734,5929,5998,6130,6179,6766,7373,7379,7875,8788,9014,9079,9219,9228,9339,	
película 8 299 8 36,73,78,5782,5790,5928,5965,5970,	
recubiertos 4 299 4 34,5780,5788,5926,	
notificaciones 1 299 1 716,	
comprimidos 4 299 4 33,5779,5787,5925,	
mg 71 299 71 32,53,299,849,858,909,919,1267,1273,1494,1538,1805,1859,1936,1990,2044,2111,2168,2344,2593,2609,2632,3294,3539,3636,3707,3717,3720,3817,3834,3856,3879,3903,3926,3970,3978,3988,3996,4060,4110,4264,4411,4613,5924,5945,6192,6742,6751,6802,6812,7160,7166,7387,7431,7699,7753,7830,7884,7938,8005,8062,8239,8488,8504,8527,9189,9434,9532,9603,9613,9616,	
adición 3 299 3 3653,4057,9549,	
25 4 299 4 31,52,1266,7159,	
señalización 2 299 2 2868,8763,	
	Januvia 2 299 2 30,5922,	
MEDICAMENTO 4 299 4 29,2726,5921,8621,	
interrumpirse 1 299 1 779,	
NOMBRE 2 299 2 27,5919,	
1 33 299 33 25,26,66,93,568,1543,1579,1615,1671,1793,1950,2207,2728,2790,3881,3937,4193,4279,5684,5786,5918,5958,5986,6461,7436,7472,7508,7564,7687,7844,8101,8623,8684,	
PRODUCTO 1 299 1 24,	
DEL 4 299 4 23,28,5892,5920,	
grupo 7 299 7 2313,4105,4137,4154,4234,4245,8208,	
CARACTERÍSTICAS 1 299 1 22,	
LAS 1 299 1 21,	
DE 10 299 10 20,2724,5838,5841,5858,5860,5870,5874,5889,8619,	
RESUMEN 1 299 1 19,	
O 1 299 1 18,	
TÉCNICA 1 299 1 17,	
FICHA 1 299 1 16,	
tuvo 9 299 9 1226,1250,4327,4368,4381,4767,5109,7119,7143,	
información 2 299 2 13,5895,	
Toda 2 299 2 11,3999,	
medicamento 5 299 5 10,15,5752,5813,5899,	
Basica 1 299 1 8,	
	Información 1 299 1 7,	
PEL 1 299 1 6,	
CON 1 299 1 5,	
RECUB 1 299 1 4,	
COMPRIMIDOS 1 299 1 3,	
50 19 299 19 2,396,857,2342,2346,3453,3706,3969,3987,4878,5784,5923,5944,6289,6750,8237,8241,9348,9602,	
100MG 1 299 1 1,	
JANUVIA 1 299 1 0,	
